close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.340 +0.040 (+3.08%)
Streaming Delayed Price Updated: 3:15 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Earnings Outlook For Neuronetics ↗
 
Via Benzinga
News headline image
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System
Advancements provide workflow efficiencies for NeuroStar® TMS providers 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update
Criteria Change Reduces Requirements for Treatment Accessibility 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
Technological advances reduce time and increase efficiency for MDD treatment 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
New updates designed to advance practice efficiency and patient outcomes 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives 
From Neuronetics
Via GlobeNewswire
News headline image
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD 
From Neuronetics
Via GlobeNewswire
News headline image
Earnings Scheduled For November 7, 2023 ↗
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
News headline image
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
Portal provides resources to raise awareness around mental health and suicide prevention 
From Neuronetics
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 210 companies reached new 52-week lows. 
Via Benzinga
News headline image
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
Award Acknowledges Excellence in Digital Marketing Efforts 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices 
From Neuronetics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During the Friday's sesion, 157 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 128 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
News headline image
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics' NeuroStar Gets Regulatory Clearance In South Korea ↗
Neuronetics, Inc. (NASDAQ: STIM) announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved multiple features of NeuroStar TMS (transcranial magnetic stimulation) for  
Via Benzinga
News headline image
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression Treatment 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
The Company expands technology for patients with obsessive-compulsive disorder 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
Lower Medication Requirement Helps Depression Patients Obtain Treatment Sooner 
From Neuronetics
Via GlobeNewswire
News headline image
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
Lowest satisfaction among medication users, highest for users of non-drug solution TMS Therapy 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
The Company is recognized for its commitment to employees’ well-being 
From Neuronetics
Via GlobeNewswire
News headline image
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
News headline image
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
Achievement demonstrates Company’s commitment to rigorous standards for safe and effective products 
From Neuronetics
Via GlobeNewswire
News headline image
Earnings Scheduled For May 9, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today